Title : DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.

Pub. Date : 2015 Jul

PMID : 26166078






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The central systolic blood pressure (SBP) has become more important than the brachial SBP in the assessment of cardiovascular risk.This case report describes the effect of vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, on the central SBP in a 54-year-old woman with hypertension and DM. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
2 The central systolic blood pressure (SBP) has become more important than the brachial SBP in the assessment of cardiovascular risk.This case report describes the effect of vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, on the central SBP in a 54-year-old woman with hypertension and DM. Vildagliptin dipeptidyl peptidase 4 Homo sapiens